Sign In | Join Free | My himfr.com
Home > Cardiac Testing Kit >

Lp-PLA2 Rapid Test Kit Cardiac Diagnostic For Physical Examination Center

WWHS Biotech.Inc(exclusive marketed by Dawin)
Contact Now
    Buy cheap Lp-PLA2 Rapid Test Kit Cardiac Diagnostic For Physical Examination Center from wholesalers
     
    Buy cheap Lp-PLA2 Rapid Test Kit Cardiac Diagnostic For Physical Examination Center from wholesalers
    • Buy cheap Lp-PLA2 Rapid Test Kit Cardiac Diagnostic For Physical Examination Center from wholesalers
    • Buy cheap Lp-PLA2 Rapid Test Kit Cardiac Diagnostic For Physical Examination Center from wholesalers
    • Buy cheap Lp-PLA2 Rapid Test Kit Cardiac Diagnostic For Physical Examination Center from wholesalers
    • Buy cheap Lp-PLA2 Rapid Test Kit Cardiac Diagnostic For Physical Examination Center from wholesalers

    Lp-PLA2 Rapid Test Kit Cardiac Diagnostic For Physical Examination Center

    Ask Lasest Price
    Brand Name : WWHS
    Model Number : Lp-PLA2
    Certification : CE
    Price : Negotiable
    Payment Terms : T/T
    Supply Ability : 50000 Kits per Week
    Delivery Time : 7 Days
    • Product Details
    • Company Profile

    Lp-PLA2 Rapid Test Kit Cardiac Diagnostic For Physical Examination Center

    【Product name】LP.pdf

    Diagnostic Kit for Lipoprotein-Associated Phospholipase A2(Immunochromatographic assay)


    [Intended Use]

    The product is applicable to in vitro quantitative test of concentration of lipoprotein phospholipase A2 (Lp-PLA2) in whole blood, plasma and serum of human body.


    [Applicable Instrument]

    NIR-1000 dry fluoroimmunoassay analyser produced by WWHS Biotech. Inc


    [Test Method]

    1. Please thoroughly read the specification before test. Frozen test card and sample should be placed at room temperature (15-30)℃ for at least 30min before use.
    2. Start NIR-1000 dry fluoroimmunoassay analyser and verify quality control according to the specification. (Note: Reagent has been calibrated in advance and calibration curve parameters of each batch of reagents have been stored in the information card. Insert the information card before use and carry out test without re-calibration after passing quality inspection; otherwise, identify the cause before test.)
    3. Take out the test card from the aluminum foil bag and use it within 15min
    4. Place the test card on a clean horizontal table top and label it.
    5. Take 10μL of sample and add it into 600μL sample diluent. Then, mix the solution evenly, take 100μL of the solution and add it into the test card well.
    6. Insert the test card into NIR-1000 dry fluoroimmunoassay analyser and press “Timing test” to keep time for 10min automatically. The analyzer will judge and read the test result automatically and display it in the screen. Or insert the test card into the analyzer after 10min and press “Instant test”, the instrument will judge and read the test result automatically.


    WWHS Assay list     
    Cardiac     
    cat#.Product itemSpecimenReaction TimeMeasure RangeClinical RangeItended Use
    1cTnIWB/Serum/Plasma12min.0.1-40ng/ml<0.3ng/mlseveral heart diseases including myocardial infarction and heart failure.
    2MyoWB/Serum/Plasma12min.5-400ng/ml<58ng/mlacute myocardial infarction (AMI) in early stage.
    3CK-MBWB/Serum/Plasma12min.1-200ng/ml<5ng/mlacute myocardial infarction (AMI) in early stage.
    4NT-proBNPWB/Serum/Plasma10min.20-35000pg/mlUnder 75:0~347pg/mL,
    Over 75:0~449pg/mL
    heart failure .
    5D-DimerWB/Plasma10min.40-10000ng/ml<500ng/mldisseminated intravascular coagulation (DIC),deep vein thrombosis (DVT),pulmonary embolism (PE), myocardial infarction, cerebral infarction, etc.
    6cTnI+Myo+CKMBWB/Serum/Plasma12min.same with single itemsame with single itemTriple marker of myocardial infarction.
    7ST2WB/Serum/Plasma10min.10-400ng/ml<35ng/mlheart failure .
    8Lp-PLA2WB/Serum/Plasma10min.10-900ng/ml<175ng/mlRisk evaluation of ACS and atherosclerotic ischemic stroke patients.
    9S100-βWB/Serum/Plasma10min.0.05-10ng/ml<0.2ng/mlCerebral infarction, cerebral injury.
    Inflammation     
    10CRP / hs-CRPWB/Serum/Plasma3min.0.5-200mg/LCRP<10mg/L,hs-CRP<1mg/Lnonspecficity inflammatory marker.
    11SAASerum5min.1-200mg/L<10mg/Linflammation&infection.
    12PCTWB/Serum/Plasma10min.0.2-100ng/ml<0.5ng/mlSepsis
    13CRP+SAAWB/Serum/Plasma5min.same with single itemsame with single iteminflammation&infection.
    14IL-6WB/Serum/Plasma10min.5-4000pg/ml10pg/mldiabetes,rheumatoid arthritis,etc
    Thyroid Hormone     
    15TSHSerum/Plasma15min.0.3-100mU/L0.35-5mU/Lhyperthyroidism and hypothyroidism
    16TT3Serum/Plasma15min.0.5-10nmol/L1.3-3.1nmol/Lthyroid dysfunction
    17TT4Serum/Plasma15min.5-300nmol/L66-181nmol/Lthyroid dysfunction
    18FT3Serum/Plasma15min.1-100pmol/L4-10pmol/Lthyroid dysfunction
    19FT4Serum/Plasma15min.5-300pmol/L19-39pmol/Lthyroid dysfunction
    Tumor Marker     
    20AFPSerum/Plasma15min.2.5-200ng/ml<20ng/mlpregnancy cancer
    21CEASerum/Plasma15min.1-200ng/ml<5ng/mlcolon cancer, colorectal cancer,etc.
    22NSESerum/Plasma15min.1-400ng/ml<16ng/mlnon-small cell lung cancer
    23FOBfecal specimens10min.50-1000ng/ml<100ng/mlAbnormal recessive gastrointestinal bleeding
    24PG IISerum/Plasma15min.1-100ug/LPGI/PGII>3.0gastric abnormalities
    25PG ISerum/Plasma15min.2.5-200ug/L>70ng/mlgastric abnormalities
    26TPSASerum/Plasma15min.0.5-40ng/ml<4ng/mlprostate cancer
    27FPSASerum/Plasma15min.0.1-10ng/ml<1ng/mlprostate cancer
    28CA12-5Serum/Plasma15min.20-500U/ml<35U/mlovarian cancer
    29CA15-3Serum/Plasma15min.10-400U/ml< 25 U/mLbreast cancer
    30HE4Serum/Plasma15min.50-2000pmol/L<140 pmol/Lovarian cancer
    31CA19-9Serum/Plasma15min.10-400U/ml< 27 U/mLpancreatic cancer
    32β-HCGSerum/Plasma15min.5-400mIU/ml<10 mIU/mLEarly pregrancy, ectopic HCG cancer,incomplete abortion
    33CK19(Cyfra21-1)Serum/Plasma15min.0.5-50ng/ml<2.5ng/mlnon-small cell lung cancer
    Fertility     
    34HCG / β-HCGSerum/Plasma10min.5-20000mIU/ml<5 mIU/mLearly pregrancy.
    35AMHSerum/Plasma10min.0.1-16ng/mlMale: 20-60 years old, 0.92-13.89 ng/mL
    Female: 20-29 years old, 0.88-10.35 ng/mL
    30-39 years old, 0.31-7.86 ng/mL 40 -50 years old, <5. 07 ng/mL
    ovarian reserve level
    Gastrointestinal      
    36FOBfecal specimens10min.qualitativequalitativegastrointestinal hemorrhage.
    37TRFfecal specimens10min.qualitativequalitativegastrointestinal hemorrhage.
    38FOB+TRFfecal specimens10min.qualitativequalitativegastrointestinal hemorrhage.
    Infection      
    39C.PneumoniaWB/Serum/Plasma15min.qualitativequalitativeCP infection
    40M.PneumoniaWB/Serum/Plasma15min.qualitativequalitativeMP infection
    41Covid-19 Antigennasal swab, throat swab or nasal wash/aspirate specimens15min.qualitativequalitativerespiratory tract
    42Covid-19 Ab IgG/IgMWB/Serum/Plasma15min.qualitativequalitativerespiratory tract
    43FluAnasal swab, throat swab or nasal wash/aspirate specimens15min.qualitativequalitativerespiratory tract
    44FluBnasal swab, throat swab or nasal wash/aspirate specimens15min.qualitativequalitativerespiratory tract
    Renal Injury      
    45CysCWB/Serum/Plasma5min.0.4-9mg/L0.5-1.1mg/Lrenal function
    46NGALUrine10min.10-1500ng/mL<132ng/mLacute kidney injury.
    Other      
    47FERRSerum5min.10-500ng/mlMale:24ng/mL~335ng/mL,
    Female:11ng/mL~307ng/mL
    iron metabolism related diseases, such as hemochromatosis and iron deficiency anemia
    48HbA1cWB10min.4%-14%4%-6%diabetes
    49VDSerum/Plasma15min.8-70ng/mL19-57ng/mLfetation


    Quality Lp-PLA2 Rapid Test Kit Cardiac Diagnostic For Physical Examination Center for sale
    Inquiry Cart 0
    Send your message to this supplier
     
    *From:
    *To: WWHS Biotech.Inc(exclusive marketed by Dawin)
    *Subject:
    *Message:
    Characters Remaining: (0/3000)